Caffeine (CA) and caffeic acid (CAF) are two bioactive phytochemicals found richly distributed in many plant foods such as coffee in different proportions. CA, an alkaloid, is adjudged world’s most consumed food bioactive substance, while CAF is a common phenolic acid in plants. With reports of potential cardiomodulatory properties of CA and CAF, we sought to investigate if proportional combinations of CA and CAF could influence the antihypertensive properties of each compounds by assessing their effect on activities of enzymes [angiotensin-1 converting enzyme (ACE), acetylcholinesterase, arginase, monoamine oxidase, phosphodiesterase-5 (PDE-5)] relevant to hypertension in vitro. Aqueous solutions of 1 mg/ml CAF and CA was prepared; thereafter, two combinations (C1 and C2) were prepared, where C1 is 5CA: 1CAF and C2 is 10CA: 1CAF. These samples were subsequently used for various enzyme assays. Results showed that C1 and C2 exhibited synergistic effects by eliciting significantly higher ( P < 0.05) inhibition of enzyme activities assayed. Specifically, the inhibitory effects of C2 on ACE and PDE-5 were not significantly different ( P > 0.05) from that of standard drugs Lisinopril and Sildenafil respectively. Also, both combinations exhibited higher antioxidant properties compared to CA and CAF. Hence, results presented in this paper support that
Oriental Pharmacy and Experimental Medicine – Springer Journals
Published: Jun 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera